We further analyzed the correlation between BIRC5 expression levels and clinical characteristics of LGG, focusing primarily on tumor grade, histological subtype, chemotherapy status, IDH1 mutation, 1p/19q chromosomal co-deletion, and O[6]-methylguanine-DNA methyltransferase (MGMT) promoter methylation. This evidence concerns the gene IDH1 and neoplasm.